Robert B. Lewis
Known title: Executive VP and CFOCIK: 0001164469
Associated companies
Transaction History
| SLGN | ▲ Buy | Grant | 3,254 | — | 5/27/2026 | View on chart |
| SLGN | ▼ Sell | Tax Withholding | 7,806 | $371K | 3/1/2026 | View on chart |
| SLGN | ▼ Sell | Open Market | 11,000 | $514K | 8/22/2025 | View on chart |
| SLGN | ▼ Sell | Open Market | 10,000 | $559K | 5/19/2025 | View on chart |
| SLGN | ▼ Sell | Tax Withholding | 13,755 | $743K | 3/1/2025 | View on chart |
| SLGN | ▲ Buy | Grant | 25,000 | — | 2/27/2025 | View on chart |
| SLGN | ▼ Sell | Open Market | 20,000 | $1.1M | 2/13/2025 | View on chart |
| SLGN | ▼ Sell | Open Market | 30,000 | $1.4M | 5/10/2024 | View on chart |
| SLGN | ▼ Sell | Tax Withholding | 13,996 | $614K | 3/1/2024 | View on chart |
| SLGN | ▲ Buy | Grant | 18,400 | — | 3/1/2024 | View on chart |
| SLGN | ▲ Buy | Grant | 18,500 | — | 2/28/2024 | View on chart |
| SLGN | ▼ Sell | Open Market | 25,000 | $1.0M | 11/13/2023 | View on chart |
| SLGN | ▼ Sell | Open Market | 14,969 | $666K | 8/8/2023 | View on chart |
| SLGN | ▼ Sell | Open Market | 10,031 | $443K | 8/7/2023 | View on chart |
| SLGN | ▲ Buy | Grant | 5,700 | — | 5/30/2023 | View on chart |
| SLGN | ▼ Sell | Tax Withholding | 17,066 | $911K | 3/1/2023 | View on chart |
| SLGN | ▲ Buy | Grant | 5,700 | — | 3/1/2023 | View on chart |
| SLGN | ▲ Buy | Grant | 23,000 | — | 2/22/2023 | View on chart |
| SLGN | ▼ Sell | Open Market | 7,500 | $389K | 11/22/2022 | View on chart |
| SLGN | ▼ Sell | Open Market | 11,082 | $518K | 8/29/2022 | View on chart |
| SLGN | ▼ Sell | Open Market | 3,918 | $186K | 8/26/2022 | View on chart |
| SLGN | ▼ Sell | Tax Withholding | 30,893 | $1.3M | 3/1/2022 | View on chart |
| SLGN | ▲ Buy | Grant | 9,100 | — | 3/1/2022 | View on chart |
| SLGN | ▲ Buy | Grant | 26,500 | — | 2/23/2022 | View on chart |
| SLGN | ▼ Sell | Open Market | 20,000 | $843K | 11/22/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
UBS Cuts Silgan Price Target to $38, Maintains Neutral Rating
UBS lowered its price target for Silgan Holdings to $38 while keeping a neutral stance. This move places the bank's outlook near the bottom of the current analyst range, which extends up to $61. The stock is currently trading below its 52-week high, reflecting broader market caution.
UBS Cuts Silgan Price Target to $38, Maintains Neutral Rating. UBS lowered its price target for Silgan Holdings to $38 while keeping a neutral stance. This move places the bank's outlook near the bottom of the current analyst range, which extends up to $61. The stock is currently trading below its 52-week high, reflecting broader market caution.